A part of pharmaceutical industry Biopharmaceuticals are gradually becoming popular within the healthcare industry due to their similarity to natural biological compounds found within the human body; thus, they supply high efficacy and fewer side-effects. They form one among the fastest-growing segments of the pharmaceutical industry. Novel concepts like cell therapy (for cancer treatment) and gene therapy (offering regenerative medicine) are steadily being refined. This presents an attractive opportunity for further growth during this sector.
The efficacy and safety related to biopharmaceutical products, combined with their ability to deal with previously untreatable conditions, allows pharmaceutical companies to command high prices for innovative drugs, thus contributing significantly to their overall revenue.
In drug development process sometimes at last stages failure happened that impact on the profit margins of pharmaceutical companies. The standard norms and regulations on the safety of the excipients and medicines end in the necessity to upgrade current manufacturing and quality assurance practice thus adds to the general manufacturing cost.
Covid-19 Impact on Pharmaceutical Excipients Market:
In addition, the present Global Market study offers an in depth analysis of the present COVID-19 pandemic impact on the market growth and its influence on the longer term growth of the worldwide Market. The recently published report demonstrates the elevation within the demand for the healthcare sector. The healthcare manufacturers have experienced future also as short term effect which incorporates supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption might be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and makers to the limit. In addition to the present, panic conditions have already spurred the demand for several healthcare products and services which are discussed intimately during this report. Moreover, the impact of this pandemic on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Pharmaceutical Excipients Market Segment Overview
By Type segment, the organic chemicals segment accounted for the biggest market share. This segment is additionally projected to register the highest CAGR during the forecast period. Owing to huge use of these chemicals in pharmaceuticals formulations.
By Applied on Function, fillers & diluents held the biggest share in 2020. The demand for fillers and diluents is high as they're utilized in manufacturing tablets and capsules. .
By End-users, the pharmaceutical and biotechnology companies accounted for the most important share of this market in 2020. This share is attributed to the rising R&D efforts by these companies.
Market Analysis, Insights and Forecast – By Type
· Organic Chemicals
· Inorganic Chemicals
· Others
Market Analysis, Insights and Forecast – By Applied On Function
· Fillers and Diluents
· Suspending and Viscosity Agents
· Coating Agents
· Binders
· Flavoring Agents and Sweeteners
· Disintegrants
· Colorants
· Lubricants and Glidants
· Preservatives
· Emulsifying Agents
· Other
Market Analysis, Insights and Forecast – By End Users
· Pharmaceutical & Biotechnology companies
· Contract Research Organisations (CROs)
· Medical Devices Companies
· Other
Pharmaceutical Excipients Market Regional Overview
Region-wise, in terms of regions, North America accounted for the biggest share of the clinical trial supplies market, followed by Europe & Asia Pacific. The growing number of registered clinical trials and significant investments in R&D for clinical trials during this region are major factors driving the expansion of the North American market.
Pharmaceutical Excipients Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Pharmaceutical Excipients Market Competitor overview
Some key developments and strategies adopted by manufacturers in the Pharmaceutical Excipients are highlighted below.
· In April 2021, Thermo Fisher announced plans to acquire PPD to enhance its offerings in clinical research services and to support clinical trials
Pharmaceutical Excipients Market, Key Players
· Thermo Fisher
· Catalent, Inc.
· Parexel
· Eurofins
· UDG Healthcare
· Piramal Pharma Solutions
· Almac Group
· PCI Pharma Services
· PRA Health Sciences
· Biocair
· Eurofins
· Marken
· Infosys
· Liveo Research
· Capsugel
· SIRO Clinpharm
· KLIFO A/S
· Clinigen
· Ancillare
· N-SIDE
· ADAllen
· Rubicon
· Durbin
· Recipharm
· Seveillar
· Myonex
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Pharmaceutical Excipients Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Type
- 5.2.1. Organic Chemicals
- 5.2.2. Inorganic Chemicals
- 5.2.3. Others
- 5.3. Market Analysis, Insights and Forecast – By Applied On Function
- 5.3.1. Fillers and Diluents
- 5.3.2. Suspending and Viscosity Agents
- 5.3.3. Coating Agents
- 5.3.4. Binders
- 5.3.5. Flavoring Agents and Sweeteners
- 5.3.6. Disintegrates
- 5.3.7. Colorants
- 5.3.8. Lubricants and Glidants
- 5.3.9. Preservatives
- 5.3.10. Emulsifying Agents
- 5.3.11. Other
- 5.4. Market Analysis, Insights and Forecast – By End Users
- 5.4.1. Pharmaceutical & Biotechnology companies
- 5.4.2. Contract Research Organisations (CROs)
- 5.4.3. Medical Devices Companies
- 5.4.4. Other
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America, Middle East, and Africa
6. North America Pharmaceutical Excipients Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Type
- 6.2.1. Organic Chemicals
- 6.2.2. Inorganic Chemicals
- 6.2.3. Others
- 6.3. Market Analysis, Insights and Forecast – By Applied On Function
- 6.3.1. Fillers and Diluents
- 6.3.2. Suspending and Viscosity Agents
- 6.3.3. Coating Agents
- 6.3.4. Binders
- 6.3.5. Flavoring Agents and Sweeteners
- 6.3.6. Disintegrants
- 6.3.7. Colorants
- 6.3.8. Lubricants and Glidants
- 6.3.9. Preservatives
- 6.3.10. Emulsifying Agents
- 6.3.11. Other
- 6.4. Market Analysis, Insights and Forecast – By End Users
- 6.4.1. Pharmaceutical & Biotechnology companies
- 6.4.2. Contract Research Organisations (CROs)
- 6.4.3. Medical Devices Companies
- 6.4.4. Other
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Pharmaceutical Excipients Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Type
- 7.2.1. Organic Chemicals
- 7.2.2. Inorganic Chemicals
- 7.2.3. Others
- 7.3. Market Analysis, Insights and Forecast – By Applied On Function
- 7.3.1. Fillers and Diluents
- 7.3.2. Suspending and Viscosity Agents
- 7.3.3. Coating Agents
- 7.3.4. Binders
- 7.3.5. Flavoring Agents and Sweeteners
- 7.3.6. Disintegrants
- 7.3.7. Colorants
- 7.3.8. Lubricants and Glidants
- 7.3.9. Preservatives
- 7.3.10. Emulsifying Agents
- 7.3.11. Other
- 7.4. Market Analysis, Insights and Forecast – By End Users
- 7.4.1. Pharmaceutical & Biotechnology companies
- 7.4.2. Contract Research Organisations (CROs)
- 7.4.3. Medical Devices Companies
- 7.4.4. Other
- 7.5. Market Analysis, Insights and Forecast – By Country
- 7.5.1. UK
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Russia
- 7.5.7. Rest of Europe
8. Asia Pacific Pharmaceutical Excipients Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Type
- 8.2.1. Organic Chemicals
- 8.2.2. Inorganic Chemicals
- 8.2.3. Others
- 8.3. Market Analysis, Insights and Forecast – By Applied On Function
- 8.3.1. Fillers and Diluents
- 8.3.2. Suspending and Viscosity Agents
- 8.3.3. Coating Agents
- 8.3.4. Binders
- 8.3.5. Flavoring Agents and Sweeteners
- 8.3.6. Disintegrants
- 8.3.7. Colorants
- 8.3.8. Lubricants and Glidants
- 8.3.9. Preservatives
- 8.3.10. Emulsifying Agents
- 8.3.11. Other
- 8.4. Market Analysis, Insights and Forecast – By End Users
- 8.4.1. Pharmaceutical & Biotechnology companies
- 8.4.2. Contract Research Organisations (CROs)
- 8.4.3. Medical Devices Companies
- 8.4.4. Other
- 8.5. Market Analysis, Insights and Forecast – By Country
- 8.5.1. China
- 8.5.2. India
- 8.5.3. Japan
- 8.5.4. Australia
- 8.5.5. South East Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America, Middle East, and Africa Pharmaceutical Excipients Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Type
- 9.2.1. Organic Chemicals
- 9.2.2. Inorganic Chemicals
- 9.2.3. Others
- 9.3. Market Analysis, Insights and Forecast – By Applied On Function
- 9.3.1. Fillers and Diluents
- 9.3.2. Suspending and Viscosity Agents
- 9.3.3. Coating Agents
- 9.3.4. Binders
- 9.3.5. Flavoring Agents and Sweeteners
- 9.3.6. Disintegrants
- 9.3.7. Colorants
- 9.3.8. Lubricants and Glidants
- 9.3.9. Preservatives
- 9.3.10. Emulsifying Agents
- 9.3.11. Other
- 9.4. Market Analysis, Insights and Forecast – By End Users
- 9.4.1. Pharmaceutical & Biotechnology companies
- 9.4.2. Contract Research Organisations (CROs)
- 9.4.3. Medical Devices Companies
- 9.4.4. Other
- 9.5. Market Analysis, Insights and Forecast – By Country
- 9.5.1. Brazil
- 9.5.2. Saudi Arabia
- 9.5.3. UAE
- 9.5.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Thermo Fisher
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Catalent, Inc.
- 10.6. Parexel
- 10.7. Eurofins
- 10.8. UDG Healthcare
- 10.9. Piramal Pharma Solutions
- 10.10. Almac Group
- 10.11. PCI Pharma Services
- 10.12. PRA Health Sciences
- 10.13. Biocair
- 10.14. Eurofins
- 10.15. Marken
- 10.16. Infosys
- 10.17. Liveo Research
- 10.18. Capsugel
- 10.19. SIRO Clinpharm
- 10.20. KLIFO A/S
- 10.21. Clinigen
- 10.22. Ancillare
- 10.23. N-SIDE
- 10.24. ADAllen
- 10.25. Rubicon
- 10.26. Durbin
- 10.27. Recipharm
- 10.28. Seveillar
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
